Preventing Chronic Disease | Testing for Human Immunodeficiency Virus Among Cancer Survivors Under Age 65 in the United States - CDC
Knowing the human immunodeficiency virus (HIV) serostatus of patients at the time of cancer diagnosis or cancer recurrence is prerequisite to coordinating HIV and cancer treatments and improving treatment outcomes. However, there are no published data about HIV testing among cancer survivors in the United States. We sought to provide estimates of the proportion of cancer survivors tested for HIV and to characterize factors associated with having had HIV testing.
Media Type: Html
- SourceUrl: http://www.cdc.gov/pcd/issues/2014/14_0274.htm
- Syndication ID: 12032
- Language: English
- Source: Centers for Disease Control and Prevention (CDC)
- Date Syndication Captured: Monday, May 23, 2016 at 10:51 PM
- Date Syndication Updated: Tuesday, May 24, 2016 at 01:50 AM
Tags
General:
CDC
Behavioral Risk Factor Surveillance System
Preventing Chronic Disease
PCD
cancer survivor
Human immunodeficiency virus testing
Embed Code Snippet
To get the embed code snippet please Login.
